Efficacy of Treatment of Cellulite Using Carboxy TherapyNCT05405062
Carboxytherapy Versus Short-pulsed Nd Yag Laser in Cellulite
A study testing Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision in people with Efficacy of Treatment of Cellulite Using Carboxy Therapy, run by Cairo University.
Trial summary
To evaluate the efficacy of carboxytherapy versus short-pulsed 1064 nm Nd-YAG laser combined with subcision in treatment of cellulite using clinical assessment and ultrasound imaging. Read more about this study
- Who is it for?
- Ages 18 to 60 years, women only
- Conditions the study is for
- Efficacy of Treatment of Cellulite Using Carboxy Therapy
- What is being tested?
- Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision
- Type of treatment
- Injection or infusion, Medical device
- Could I receive a placebo?
- No, everyone receives an active treatment
- How many people
- 30 participants
- Where
- No sites listed yet
- Study dates
- 1 Jun 2022to 15 Sep 2022
- Phase
- Interventional
- Are there results?
- None posted in the registry
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 18 to 60 years
- Women only
- No healthy volunteers
- Adult
Who may be able to join
- Females between 18 and 60 years
- Females with cellulite; stage 2 or 3 according to Nurnberger-Muller Scale (Nurnberger and Muller, 1978)
Who cannot join
- Subjects that have had liposuction or surgical procedures to remove fat in the past 6 months
- Personal or family history of keloid formation or scarring
- Pregnant or lactating females
- Significant concomitant illness (e.g. renal, cardiac, hepatic, autoimmune conditions)
- Known history of bleeding tendency or receiving antiplatelet or anticoagulant therapy
- History of uncontrolled diabetes
Show all 9Show fewer
- History of thrombophlebitis within the last 2 years
- Subjects with active infections
- Subjects on long term corticosteroid or immunosuppressive therapy
About this study
Official title: Efficacy of Carboxytherapy Versus Short-pulsed 1064 nm Nd-YAG Laser Combined With Subcision in Treatment of Cellulite
To evaluate the efficacy of carboxytherapy versus short-pulsed 1064 nm Nd-YAG laser combined with subcision in treatment of cellulite using clinical assessment and ultrasound imaging.
Read the detailed description
Study Design:
Randomized Clinical Trial
Study Methods:
The population of study: Thirty females aged from 18 to 60 years with cellulite Study location: Dermatology outpatient clinic, Faculty of Medicine, Cairo University
Inclusion criteria:
- Females between 18 and 60 years
- Females with cellulite; stage 2 or 3 according to Nurnberger-Muller Scale
Exclusion criteria:
- Subjects that have had liposuction or surgical procedures to remove fat in the past 6 months
- Personal or family history of keloid formation or scarring
- Pregnant or lactating females
- Significant concomitant illness (e.g. renal, cardiac, hepatic, autoimmune conditions)
- Known history of bleeding tendency or receiving antiplatelet or anticoagulant therapy
- History of uncontrolled diabetes
- History of thrombophlebitis within the last 2 years
- Subjects with active infections
- Subjects on long term corticosteroid or immunosuppressive therapy
All patients will be subjected to the following:
An informed written consent will be obtained from all the patients.
- Patients will be examined to assess site, stage and severity of cellulite.
- Depressed areas on gluteal region and posterolateral thighs will be selected and marked while the patient is standing.
- One side will be randomized to receive 6 carboxytherapy sessions with an interval of 2 weeks.
- The other side will receive 3 sessions of short pulsed 1064 nm Nd-YAG laser (25 joules/cm2, 2.2Hz) combined with subcision with an interval of 1 month.
- In carboxytherapy, 5 cc will be injected in each point with depth of 7mm. Between each point and the other is 5 cm.
- Subcision will be done in the center of the selected dimples.
- Systemic antibiotics will be prescribed for 5 days after subcision session.
- The whole duration of the sessions is 3 months.
- Patients will be advised to maintain a healthy diet throughout the study.
Evaluation of patients' response:
- A complete physical examination and history taking before treatment
- Evaluation will be carried out for each patient at the beginning of the study, and at the end of the study 2 weeks following the final session by:
- Standardized photography (posterior and side view)
- Photonumeric cellulite severity scale (Hexsel et al., 2009)
- Ultrasound imaging that measures percentage of reduction of subcutaneous fat and dermal thickness. The device used is Toshiba with high frequency probes: probe 18-20 MHz (for measuring skin dermal thickness) and probe 7-9MHz (for measuring subcutaneous fat thickness)
- Patient satisfaction scoring will be reported at the end of the study by patient satisfaction score (excellent, very good, good, bad, very bad) and DLQI score (Finlay and Khan, 1994).
Potential risks:
- Ecchymosis
- Pain
- Burning sensation
3- Secondary infection at injection site
Study outcomes:
- Assessment of efficacy of carboxytherapy in the treatment of cellulite (clinically by photography and photonumeric severity scale).
- Evaluating possible synergistic effect of short pulsed Nd-YAG laser combined with subcision in treatment of cellulite (clinically by photography and photonumeric severity scale).
Secondary outcome:
Comparing the reduction in subcutaneous fat and change in dermal thickness between the 2 methods by ultrasound imaging.
- Being tested
- Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
Carboxytherapy, short pulsed 1064 Nd Yag laser and subcisionDevice
Carboxytherapy is involves the injection of carbon dioxide into the subcutaneous tissue, with the goal of affecting the adipose tissue and circulation. Its mechanism of action is through an increase in capillary blood flow induced by hypercapnia and a decrease in cutaneous oxygen consumption (Pianez et al., 2016).
| Study group | Role | What they receive |
|---|---|---|
| Carboxytherapy | Active comparator | Six carboxytherapy sessions with an interval of 2 weeks. Five ccs will be injected at each point with a depth of 7mm. Between each point and the other is 5 cm. Receives: Device: Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision |
| Short pulsed 1064 nm Nd-YAG laser combined with subcision | Active comparator | Twenty-five joules/cm2, 2.2Hz combined with subcision with an interval of 1 month. Receives: Device: Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision |
What is being measured
The primary outcome is the main question the study is designed to answer.
Photonumeric cellulite severity scale
Measured: Change from baseline at 3 months
Secondary outcomes (1)
Ultrasound imaging
The device used is Toshiba with high frequency probes: probe 18-20 MHz (for measuring skin dermal thickness) and probe 7-9MHz (for measuring subcutaneous fat thickness)
Measured: Change from baseline at 3 months
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted3 Jun 2022
- Study start1 Jun 2022 (estimated)
- Primary completion15 Sep 2022 (estimated)
- Study completion15 Sep 2022 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for Efficacy of Treatment of Cellulite Using Carboxy TherapyStudies of the same condition, open and under way.
- More trials run by Cairo UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Interventional
- Phase
- Phase N/A
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind
- Who is masked
- Outcomes assessor
- Enrolment
- 30 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Cairo University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Hagar El Sayed, Cairo University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT05405062
- Sponsor's protocol ID
- Carboxy therapy and cellulite
- Status last verified
- Jun 2022
- First submitted
- 7 Jan 2022
- Last updated
- 3 Jun 2022
- Results posted
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
Study at a glance
From the registry record, last updated by the sponsor on 3 Jun 2022. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- Efficacy of Carboxytherapy Versus Short-pulsed 1064 nm Nd-YAG Laser Combined With Subcision in Treatment of Cellulite
- ClinicalTrials.gov ID
- NCT05405062
- Acronym / sponsor ID
- Carboxy therapy and cellulite
- Study type
- Interventional
- Recruitment status
- Unknown status
- Enrolment
- 30 participants (estimated)
- Lead sponsor
- Cairo UniversityUniversity, hospital or other
- Study start
- 1 Jun 2022 (estimated)
- Primary completion
- 15 Sep 2022 (estimated)
- Study completion
- 15 Sep 2022 (estimated)
- First posted
- 3 Jun 2022 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
To evaluate the efficacy of carboxytherapy versus short-pulsed 1064 nm Nd-YAG laser combined with subcision in treatment of cellulite using clinical assessment and ultrasound imaging.
Detailed description
Study Design:
Randomized Clinical Trial
Study Methods:
The population of study: Thirty females aged from 18 to 60 years with cellulite Study location: Dermatology outpatient clinic, Faculty of Medicine, Cairo University
Inclusion criteria:
- Females between 18 and 60 years
- Females with cellulite; stage 2 or 3 according to Nurnberger-Muller Scale
Exclusion criteria:
- Subjects that have had liposuction or surgical procedures to remove fat in the past 6 months
- Personal or family history of keloid formation or scarring
- Pregnant or lactating females
- Significant concomitant illness (e.g. renal, cardiac, hepatic, autoimmune conditions)
- Known history of bleeding tendency or receiving antiplatelet or anticoagulant therapy
- History of uncontrolled diabetes
- History of thrombophlebitis within the last 2 years
- Subjects with active infections
- Subjects on long term corticosteroid or immunosuppressive therapy
All patients will be subjected to the following:
An informed written consent will be obtained from all the patients.
- Patients will be examined to assess site, stage and severity of cellulite.
- Depressed areas on gluteal region and posterolateral thighs will be selected and marked while the patient is standing.
- One side will be randomized to receive 6 carboxytherapy sessions with an interval of 2 weeks.
- The other side will receive 3 sessions of short pulsed 1064 nm Nd-YAG laser (25 joules/cm2, 2.2Hz) combined with subcision with an interval of 1 month.
- In carboxytherapy, 5 cc will be injected in each point with depth of 7mm. Between each point and the other is 5 cm.
- Subcision will be done in the center of the selected dimples.
- Systemic antibiotics will be prescribed for 5 days after subcision session.
- The whole duration of the sessions is 3 months.
- Patients will be advised to maintain a healthy diet throughout the study.
Evaluation of patients' response:
- A complete physical examination and history taking before treatment
- Evaluation will be carried out for each patient at the beginning of the study, and at the end of the study 2 weeks following the final session by:
- Standardized photography (posterior and side view)
- Photonumeric cellulite severity scale (Hexsel et al., 2009)
- Ultrasound imaging that measures percentage of reduction of subcutaneous fat and dermal thickness. The device used is Toshiba with high frequency probes: probe 18-20 MHz (for measuring skin dermal thickness) and probe 7-9MHz (for measuring subcutaneous fat thickness)
- Patient satisfaction scoring will be reported at the end of the study by patient satisfaction score (excellent, very good, good, bad, very bad) and DLQI score (Finlay and Khan, 1994).
Potential risks:
- Ecchymosis
- Pain
- Burning sensation
3- Secondary infection at injection site
Study outcomes:
- Assessment of efficacy of carboxytherapy in the treatment of cellulite (clinically by photography and photonumeric severity scale).
- Evaluating possible synergistic effect of short pulsed Nd-YAG laser combined with subcision in treatment of cellulite (clinically by photography and photonumeric severity scale).
Secondary outcome:
Comparing the reduction in subcutaneous fat and change in dermal thickness between the 2 methods by ultrasound imaging.
Study design
- Primary purpose
- Treatment
- Allocation
- Randomised
- Intervention model
- Parallel groups
- Masking
- Single blind (outcomes assessor)
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Carboxytherapy | Active comparator | Device: Carboxytherapy, short pulsed 1064 Nd Yag laser and subcisionSix carboxytherapy sessions with an interval of 2 weeks. Five ccs will be injected at each point with a depth of 7mm. Between each point and the other is 5 cm. |
| Short pulsed 1064 nm Nd-YAG laser combined with subcision | Active comparator | Device: Carboxytherapy, short pulsed 1064 Nd Yag laser and subcisionTwenty-five joules/cm2, 2.2Hz combined with subcision with an interval of 1 month. |
Who may qualify
- Ages
- 18 to 60 years
- Sex
- Female only
- Healthy volunteers
- Not accepted
- Age groups
- Adult
Key inclusion criteria (2 listed)
- Females between 18 and 60 years
- Females with cellulite; stage 2 or 3 according to Nurnberger-Muller Scale (Nurnberger and Muller, 1978)
Key exclusion criteria (9 listed)
- Subjects that have had liposuction or surgical procedures to remove fat in the past 6 months
- Personal or family history of keloid formation or scarring
- Pregnant or lactating females
- Significant concomitant illness (e.g. renal, cardiac, hepatic, autoimmune conditions)
- Known history of bleeding tendency or receiving antiplatelet or anticoagulant therapy
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Interventions
| Intervention | Type | Arms |
|---|---|---|
| Carboxytherapy, short pulsed 1064 Nd Yag laser and subcisionCarboxytherapy is involves the injection of carbon dioxide into the subcutaneous tissue, with the goal of affecting the adipose tissue and circulation. Its mechanism of action is through an increase in capillary blood flow induced by hypercapnia and a decrease in cutaneous oxygen consumption (Pianez et al., 2016). | Device | Carboxytherapy, Short pulsed 1064 nm Nd-YAG laser combined with subcision |
Primary outcome
Photonumeric cellulite severity scale
Time frame: Change from baseline at 3 months
1 secondary outcome
Ultrasound imaging
Time frame: Change from baseline at 3 months
Results and safety
Results are not available in the source record.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 3 Jun 2022.
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part. This study is not recruiting at the moment.
The record lists no contact. Use the official record to reach the sponsor.
Questions about this trial
What is this clinical trial studying?
A study testing Carboxytherapy, short pulsed 1064 Nd Yag laser and subcision in people with Efficacy of Treatment of Cellulite Using Carboxy Therapy, run by Cairo University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 2 inclusion and 9 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: status not confirmed, as of the sponsor's last update on 3 Jun 2022. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
Results are not available in the source record.
How can a doctor refer a patient or contact the research team?
The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Photonumeric cellulite severity scale (time frame: Change from baseline at 3 months). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 3 Jun 2022.